ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A
Legitimising Unaffordable Medicine Prices?

Draft Drug Price Policy 2011

Pursuing its neo-liberal agenda of decontrol and liberalisation, the present government is planning to move towards market-based pricing from the current cost-plus-based pricing mechanism for drugs under price control. By refusing to include fi xed dose combinations of essential medicines, sticking only to dosages and strengths involving essential drugs and leaving out "me too" drugs in similar therapeutic classes, the government is designing escape routes for companies to wriggle out of the price control mechanism.



Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

649for India

$20for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top